Call Boomerang Books 1300 36 33 32

Description - Aminoglycoside Antibiotics by Dev P. Arya

Advances that open new avenues in developing aminoglycoside antibiotics During the last twenty years, there have been numerous advances in the understanding of the chemistry, biochemistry, and recognition of aminoglycosides. This has led to the development of novel antibiotics and opened up new therapeutic targets for intervention. This is the first book to provide a complete overview of recent advances in the field and explore their tremendous potential for drug discovery and rational drug design. With chapters written by one or more leading experts in their specialty areas, the book addresses the chemistry, biology, and toxicology of aminoglycosides. Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery is a great resource for academic and industrial researchers in drug design and mechanism studies and for researchers studying antibiotic resistance, antibiotic design and synthesis, and the discovery of novel pharmaceuticals. It is also a valuable reference for graduate students in pharmacy, pharmaceutical science, biophysics, medicinal chemistry, and chemical biology.

Buy Aminoglycoside Antibiotics by Dev P. Arya from Australia's Online Independent Bookstore, Boomerang Books.

Book Details

ISBN: 9780471743026
ISBN-10: 047174302X
Format: Hardback
(235mm x 161mm x 22mm)
Pages: 320
Imprint: Wiley-Blackwell (an imprint of John Wiley & Sons Ltd)
Publisher: John Wiley and Sons Ltd
Publish Date: 29-Jun-2007
Country of Publication: United Kingdom

Book Reviews - Aminoglycoside Antibiotics by Dev P. Arya

» Have you read this book? We'd like to know what you think about it - write a review about Aminoglycoside Antibiotics book by Dev P. Arya and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a Boomerang Books Account Holder - it's free to sign up and there are great benefits!)

Write Review


Author Biography - Dev P. Arya

Dev P. Arya is an Associate Professor of Chemistry and Director of the Laboratory of Medicinal Chemistry at Clemson University. He is a member of the ACS, and currently serves as the Program Chair of the Division of Carbohydrate Chemistry. His research interests lie in the development of nucleic acid targeted drugs.